Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.
about
Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophiliaStenotrophomonas maltophilia: an emerging global opportunistic pathogenEffects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilmImpact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistanceMultiparameter assessments to determine the effects of sugars and antimicrobials on a polymicrobial oral biofilm.Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.BsmR degrades c-di-GMP to modulate biofilm formation of nosocomial pathogen Stenotrophomonas maltophilia.Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophiliaStenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis.Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence.Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm.Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coliEffects of Fluoroquinolones and Azithromycin on Biofilm Formation of Stenotrophomonas maltophilia.Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis.Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.Plant extracts: initial screening, identification of bioactive compounds and effect against Candida albicans biofilms.Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus.Critical review on biofilm methods.Synergistic activity between an antimicrobial polyacrylamide and daptomycin versus Staphylococcus aureus biofilm.Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis.Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient.In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus.Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm.Pentacyclic triterpenes combined with ciprofloxacin help to eradicate the biofilm formed in vitro by Escherichia coli.Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.In vitro antibacterial and antibiofilm activities of chlorogenic acid against clinical isolates of Stenotrophomonas maltophilia including the trimethoprim/sulfamethoxazole resistant strain.Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms.AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.Effect of sub-minimum inhibitory concentrations of ciprofloxacin, amikacin and colistin on biofilm formation and virulence factors of Escherichia coli planktonic and biofilm forms isolated from human urine.Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.Salmonella enterica Enteritidis biofilm formation and viability on regular and triclosan-impregnated bench cover materials.Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents.Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study.Anti-biofilm and Anti-Virulence Efficacy of Celastrol Against Stenotrophomonas maltophilia.
P2860
Q24672751-859D5D05-B2A5-45B3-BA54-1E78C4C118CCQ26995336-A677B6C3-0375-4450-A9C5-9C9C509EAC6DQ28541755-872F1441-6F85-4A78-B49A-4FFDB8582B0EQ31138535-3062E11F-FBF3-426B-A828-77F2AAE0A456Q33258644-E7975FF9-EA62-4C72-98DD-C18B61248E33Q33259370-DA153FB2-7FB5-49B5-8702-8166F4C761DFQ33550582-A799FAE8-CC9F-4914-85E7-D298C2177C6FQ33875633-2EEC8354-544A-491B-957D-B0DA5C4EE9B8Q33950924-62AA49F0-BC7B-48C8-9986-074FB5851D24Q34294110-D3CD3D5B-29B7-4ED4-931F-886AC3ADD6A2Q35106279-B205BEE7-0558-4BF1-9C50-BA0F80AEBDA2Q35108518-3434F5FB-E143-4E44-BDFA-7F7DCF7F4E72Q36026123-B7DDC98D-AAED-4FA0-88B6-49C24DEDBCF8Q36199673-1B57F249-4087-410E-B8D0-6927C08F7B7AQ36390080-797F9ADA-F1B7-47E8-87B8-8CD13FCC21FEQ37089532-A44C25D1-2FE8-49EC-B5AA-F1B74C940A45Q37546291-A5DC5B1F-989E-4ABC-9EF2-BB2A6C70B211Q38247296-CC8D2298-1DF2-4C89-BB9A-3C9E61FAA434Q38786620-661A4277-C618-406F-9479-C0D14D2479F1Q38820731-7CD4D7DF-7303-4F1A-B0E7-341CC9F55EBAQ39015075-F273FDC7-5F5C-45C2-8EA5-86B1BB8AB7CCQ39787013-44F78B54-5EB7-4780-AE62-D6FF4534EC8FQ40078486-0465A46A-60FE-4309-97AD-AFC40582A803Q40504881-009E97FD-15D8-4E5C-B486-CCF8E9CD2891Q40652733-59478FBE-7150-477D-8C39-B3606D03C4D9Q40772432-E6E7C599-1115-44F5-8FD7-28713FFB01BDQ40964077-30E79C9B-F282-4025-8A2D-47961C7B1F0CQ41010400-83527A95-E4FD-4D64-B688-093D07C33C95Q41453012-B39D9843-F714-4D04-8823-1C0A9249A015Q41481610-BA80F2A7-67CE-42A0-A2FD-B9750A0D88A2Q41837042-05F2E5AA-30DD-46E4-A162-EDF853732889Q42112385-9B6B9BCC-596C-4C41-95A7-98D79B5247DEQ42939902-AB5011F4-4A8A-4A1F-99FE-498EB9B5AB7FQ42946344-92DEDBAF-73A0-4A82-953B-41673A05E26FQ43325120-D0431057-4FDC-4562-B3B1-7C692B6E4AC2Q44689052-D137BCC5-4277-4A8C-BE24-43F3DE1AE88FQ46604526-1C634B81-A68B-463E-8B43-49888AEE8B1BQ47126542-DE13405A-9612-45B9-AA4D-67C9AD0041B9Q47155202-36557AE0-5CD1-445F-B1B9-27FEA7CA9C12Q53688076-CE54B7D0-8C50-4965-A476-CCD4A3B70FBD
P2860
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biofilm formation by Stenotrop ...... amethoxazole, and ceftazidime.
@en
type
label
Biofilm formation by Stenotrop ...... amethoxazole, and ceftazidime.
@en
prefLabel
Biofilm formation by Stenotrop ...... amethoxazole, and ceftazidime.
@en
P2093
P2860
P1476
Biofilm formation by Stenotrop ...... famethoxazole, and ceftazidime
@en
P2093
Domenico D'Antonio
Ilaria Spedicato
Raffaele Piccolomini
P2860
P304
P356
10.1128/AAC.48.1.151-160.2004
P407
P577
2004-01-01T00:00:00Z